Global Research Clinical Trial Supplies Market Analysis and Review | Page 2
Clinical trial supplies could be explored by clinical phase as Phase III, Phase II, Phase I, and Others. The “Phase I clinical
trials” segment led the clinical trial supplies market in 2017 and will continue to lead in the forecast period. The key
factors that may be attributed to the growth of market includes increasing number of Phase I clinical trials being
outsourced, high investment in this sector, increasing globalization and less sample population for outsourcing the
main volume of these trials.
Get a Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/clinical-trial-supplies-market/request-sample
Based on product/service type, the market could span Storage & distribution (Non-cold chain based, and Cold chain
based), Manufacturing and Supply chain management. The market could be explored based on therapeutic use as
Cardiovascular, CNS, Oncology, Metabolic disorders, Infectious disease, and Others. The “Oncology” segment led the
market in 2017 and will continue to lead in the forecast period.
See More Reports of This Category by Million Insights @
https://www.millioninsights.com/industry/pharmaceuticals
Market Segment:
This report studies the global Clinical Trial Supplies market, analyzes and researches the Clinical Trial Supplies
development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses
on the top players in global market, like
• Alamc Group
• Catalent Pharma Solutions
• KLIFO A/S
• Movianto
• PCI Services
• Patheon
• PAREXEL International